Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CCR3 Antikörper (DyLight 488)

Der Kaninchen Polyklonal Anti-CCR3-Antikörper wurde für FACS validiert. Er ist geeignet, CCR3 in Proben von Human zu detektieren.
Produktnummer ABIN7354674

Kurzübersicht für CCR3 Antikörper (DyLight 488) (ABIN7354674)

Target

Alle CCR3 Antikörper anzeigen
CCR3 (Chemokine (C-C Motif) Receptor 3 (CCR3))

Reaktivität

  • 93
  • 35
  • 26
  • 4
Human

Wirt

  • 63
  • 23
  • 8
  • 5
Kaninchen

Klonalität

  • 64
  • 34
  • 1
Polyklonal

Konjugat

  • 48
  • 9
  • 7
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CCR3 Antikörper ist konjugiert mit DyLight 488

Applikation

  • 55
  • 36
  • 28
  • 27
  • 13
  • 13
  • 13
  • 9
  • 8
  • 7
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)
  • Verwendungszweck

    Anti-Human CCR3 DyLight® 488 conjugated Antibody

    Sequenz

    MTTSLDTVET FGTTSYYDDV GLLCEKADTR ALMA

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins.

    Produktmerkmale

    Anti-Human CCR3 DyLight® 488 conjugated Antibody -Dyl488. Tested in Flow Cytometry applications. This antibody reacts with Human.

    Immunogen

    A synthetic peptide corresponding to a sequence at the N-terminus of human CCR3.

    Isotyp

    IgG
  • Applikationshinweise

    Flow Cytometry (Fixed), 1-3 μg/1x106 cells1. Blanchard, C., Wang, N., Stringer, K. F., Mishra, A., Fulkerson, P. C., Abonia, J. P., Jameson, S. C., Kirby, C., Konikoff, M. R., Collins, M. H., Cohen, M. B., Akers, R., Hogan, S. P., Assa'ad, A. H., Putnam, P. E., Aronow, B. J., Rothenberg, M. E. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116: 536-547, 2006. 2. Takeda, A., Baffi, J. Z., Kleinman, M. E., Cho, W. G., Nozaki, M., Yamada, K., Kaneko, H., Albuquerque, R. J. C., Dridi, S., Saito, K., Raisler, B. J., Budd, S. J., and 15 others. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460: 225-230, 2009.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    Lot specific

    Buffer

    Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
  • Target

    CCR3 (Chemokine (C-C Motif) Receptor 3 (CCR3))

    Andere Bezeichnung

    CCR3

    Hintergrund

    Synonyms: C-C chemokine receptor type 3, C-C CKR-3, CC-CKR-3, CCR-3, CCR3, CKR3, Eosinophil eotaxin receptor, CD193, CCR3, CMKBR3

    Tissue Specificity: In eosinophils as well as trace amounts in neutrophils and monocytes.

    Background: C-C chemokine receptor type 3, also called CCR3 or CKR3 is a protein that in humans is encoded by the CCR3 gene. The protein encoded by this gene is a receptor for C-C type chemokines. It belongs to family 1 of the G protein-coupled receptors. This gene and seven other chemokine receptor genes form a chemokine receptor gene cluster on the chromosomal region 3p21. This receptor binds and responds to a variety of chemokines, including eotaxin (CCL11), eotaxin-3 (CCL26), MCP-3 (CCL7), MCP-4 (CCL13), and RANTES (CCL5). It is highly expressed in eosinophils and basophils, and is also detected in TH1 and TH2 cells, as well as in airway epithelial cells. This receptor may contribute to the accumulation and activation of eosinophils and other inflammatory cells in the allergic airway. It is also known to be an entry co-receptor for HIV-1. Alternatively spliced transcript variants have been described.

    Molekulargewicht

    39 kDa

    Gen-ID

    1232

    UniProt

    P51677
Sie sind hier:
Chat with us!